PRODUCT NAME:
Methotrexate Determination Kit (MTX Determination Kit)
Abbreviation: MTX
INTENDED USE:
Methotrexate Determination Kit is an in vitro diagnostic test for
the quantitative detection of MTX in human serum and plasma
specimens.
Methotrexate is a folic acid antitumor drug that widely used in
the treatment of malignant tumors such as acute lymphoblastic
leukemia, lymphoma, chorionic epithelial cancer and
osteosarcoma. High-dose methotrexate combined with calcium
leucovorin is one of the important treatments for acute
lymphoblastic leukemia, malignant lymphoma and osteosarcoma.
High-dose methotrexate chemotherapy requires MTX blood
concentration monitoring to guide the rational use of rescue drugs
and avoid the serious side effects caused by MTX. Therefore, the
monitoring of methotrexate blood concentration is a great
significance for guiding the clinical rational use of drugs in
cancer patients.